In 2023, the use of non-steroidal anti-inflammatory and antirheumatic medicines in Germany stood as a baseline for forthcoming trends. Forecasted data for 2024 to 2028 shows a modest and steady annual increase ranging from 35.9 to 36.3 units per thousand persons per day.
The year-on-year growth rate is approximately 0.28%, indicating sluggish yet consistent growth. The compound annual growth rate (CAGR) over this period reflects a similar gentle upward trajectory, highlighting a stable market demand for these medicines.
Future trends to watch for include the impact of emerging therapies, healthcare policy changes, and demographic shifts such as an aging population which may influence the uptake of anti-inflammatory treatments.
